Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- HEART112(7) · pp.391 · 2026
- 피인용
- Web of Science 2Scopus 2
- FWCI (Scopus)
- 0.31
- JCR IF
- JCR 2024 4.4
- ISSN
- 1355-6037
저자
- Cho, Min Soo제1저자Asan Med Ctr, Heart Inst, Seoul, South Korea
- Kang, Do-YoonAsan Med Ctr, Seoul, South Korea
- Lee, Jung-BokAsan Med Ctr, Seoul, South Korea
- Oh, Yong-SeogCatholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea
- Lee, Chang HoonVet Hlth Serv Med Ctr, Seoul, South Korea
- Choi, Eue-KeunSeoul Natl Univ Hosp, Seoul, South Korea
- Lee, Ji HyunBundang Seoul Natl Univ Hosp Dept Internal Med, Cardiol, Seongnam, South Korea
- Kwon, Chang HeeKonkuk Univ, Med Ctr, Cardiol, Seoul, South Korea
- Park, Gyung-MinUlsan Univ Hosp, Cardiol, Ulsan, South Korea
- Choi, Hyung OhSoonchunhyang Univ Hosp, Cardiol, Bucheon, Bucheon, South Korea
- Park, Kyoung-HaHallym Univ, Med Ctr, Dept Internal Med, Cardiol, Anyang, South Korea
- Park, Kyoung-MinSamsung Med Ctr, Dept Med, Seoul, South Korea
- Hwang, JongminKeimyung Univ, Dongsan Hosp, Daegu, South Korea
- Yoo, Ki-DongCatholic Univ Korea, St Vincents Hosp, Internal Med, Suwon, South Korea
- Cho, Young RakDong A Univ, Coll Med, Dong A Med Ctr, Pusan, South Korea
- Kim, Ji-HyunDongguk Univ, Internal Med, Ilsan Hosp, Goyang, South Korea
- 황기원Pusan Natl Univ, Yangsan Hosp, Yangsan, South Korea
- Jin, Eun SunKyung Hee Univ, Gangdong Hosp, Seoul, South Korea
- Kwon, OsungCatholic Univ Korea, Eunpyeong St Marys Hosp, Cardiol, Seoul, South Korea
- Kim, Ki-HunHaeundae Paik Hosp, Busan, South Korea
- Park, Duk-Woo교신저자Univ Ulsan, Coll Med, Dept Cardiol, Seoul, South Korea
- Nam, Gi-Byoung교신저자Univ Ulsan, Coll Med, Dept Cardiol, Seoul, South Korea
초록
Objective The impact of off-label underdosing of direct oral anticoagulants (DOACs) on clinical outcomes in patients with atrial fibrillation (AF) and stable coronary artery disease (CAD) remains unclear. Methods The EPIC-CAD trial (Edoxaban vs Edoxaban with antiPlatelet agent In patients with atrial fibrillation and Chronic stable Coronary Artery Disease) randomised patients with AF and stable CAD to receive either edoxaban monotherapy or dual antithrombotic therapy (edoxaban plus single antiplatelet agent). Off-label underdosing was defined as low-dose edoxaban (30 mg once daily) without standard criteria for dose reduction. The primary outcome was a composite of death, myocardial infarction, stroke, systemic embolism, unplanned revascularisation and major or clinically relevant non-major bleeding at 12 months. Results Among the 1040 randomised patients, 694 patients (66.7%) without dose-reduction criteria were included; of whom, 121 patients (17.4%) received edoxaban underdosing. At 12 months, the incidence of primary outcome was similar between standard-dose and under-dose edoxaban groups (10.5% vs 9.2%, adjusted HR 0.77, 95% CI 0.39 to 1.54). There was no significant difference in major ischaemic events (1.4% vs 1.7%, HR 1.14, 95% CI 0.22 to 5.91) and major or clinically relevant non-major bleeding (9.0% vs 8.4%, HR 0.87, 95% CI 0.42 to 1.78). Regardless of edoxaban underdosing, edoxaban monotherapy was associated with lower risk of primary net-clinical outcomes and bleeding compared with dual antithrombotic therapy. Conclusions In patients with AF and stable CAD, there was no significant difference in the rate of primary outcome between off-label underdose and standard-dose edoxaban. The benefit of edoxaban monotherapy over dual antithrombotic therapy was consistent regardless of edoxaban underdosing. However, given the analyses were underpowered and the CI was wide, the results cannot be considered clinically directive. Trial registration number URL: https://www.clinicaltrials.gov; unique identifiers: NCT03718559.
키워드
Atrial FibrillationCoronary artery diseaseANTAGONIST ORAL ANTICOAGULANTSRIVAROXABAN
식별자
- Scopus EID
- 2-s2.0-105015603145
- WoS UID
- 001569098400001



로그인
연구물 목록으로